Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

China Reports First Case of Imported Zika Virus

By Drug Discovery Trends Editor | February 10, 2016

China’s first case of the Zika virus has been found in a 34-year-old man who recently traveled to Venezuela and is now making a speedy recovery, the government said Wednesday.

The man from the southern city of Ganzhou had been treated in Venezuela on Jan. 28 before returning home on Feb. 5 via Hong Kong and the southern Chinese city of Shenzhen, the National Health and Family Planning Commission said in a statement.

The commission said he had been confirmed as having the Zika virus on Tuesday and was being treated at the Ganxian People’s Hospital. His temperature is now normal and a skin rash is receding, it said.

The commission said the chances of the virus spreading in China were “extremely low” due to cold winter temperatures and a lack of mosquito activity, the primary avenue by which Zika is transmitted.

The Zika virus is spreading rapidly through Latin America. Most people who contract it have either mild or no symptoms, but it is suspected of causing a birth defect in which babies are born with abnormally small heads.

Bernhard Schwartlander, the World Health Organization representative in Beijing, said imported cases of Zika in China are to be expected given the frequency of travel between the country and South America.

“Chinese health authorities are well prepared to respond to this and any further imported cases,” Schwartlander said in a statement issued by his office. “The current risk of a widespread outbreak of Zika virus in China is low.”

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE